First Time Loading...

Paradigm Biopharmaceuticals Ltd
ASX:PAR

Watchlist Manager
Paradigm Biopharmaceuticals Ltd Logo
Paradigm Biopharmaceuticals Ltd
ASX:PAR
Watchlist
Price: 0.275 AUD -3.51% Market Closed
Updated: May 3, 2024

Paradigm Biopharmaceuticals Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Paradigm Biopharmaceuticals Ltd
Cash from Operating Activities Peer Comparison

Comparables:
IMM
MSB
CSL
CUV
TLX

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Paradigm Biopharmaceuticals Ltd
ASX:PAR
Cash from Operating Activities
-AU$78.5m
CAGR 3-Years
-49%
CAGR 5-Years
-63%
CAGR 10-Years
N/A
Immutep Ltd
ASX:IMM
Cash from Operating Activities
-AU$35.4m
CAGR 3-Years
-34%
CAGR 5-Years
-29%
CAGR 10-Years
-10%
Mesoblast Ltd
ASX:MSB
Cash from Operating Activities
-$59.1m
CAGR 3-Years
16%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Cash from Operating Activities
$2.7B
CAGR 3-Years
-9%
CAGR 5-Years
11%
CAGR 10-Years
9%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Cash from Operating Activities
AU$42.3m
CAGR 3-Years
31%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Telix Pharmaceuticals Ltd
ASX:TLX
Cash from Operating Activities
AU$23.9m
CAGR 3-Years
130%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Paradigm Biopharmaceuticals Ltd's Cash from Operating Activities?
Cash from Operating Activities
-78.5m AUD

Based on the financial report for Dec 31, 2023, Paradigm Biopharmaceuticals Ltd's Cash from Operating Activities amounts to -78.5m AUD.

What is Paradigm Biopharmaceuticals Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-63%

Over the last year, the Cash from Operating Activities growth was -136%. The average annual Cash from Operating Activities growth rates for Paradigm Biopharmaceuticals Ltd have been -49% over the past three years , -63% over the past five years .